维普中文期刊产品整合服务
10篇 您的检索式:作者名="Haas NB"
    题名 作者 年代 出处 被引量
1Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinibfor unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial显示文摘Haas NB Manola J Uzzo RG 2015J Clin 0ncol2015,33,:1
2The role of prevalence in the diagnosis of prostate cancer显示文摘Delongchamps NB Singh A Haas GP 2006Cancer Control2006,13,3:1
3A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802显示文摘Haas NB Lin X Manola J 2012Med Oncol2012,29,2:1
4A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features : ECOG 8802 显示文摘Haas NB Lin X Manola J 2012Med Oncol2012,29,:1
5Needle Biopsies on Autopsy Prostates:Sensitivity of Cancer Detection Based on True Prevalence显示文摘Haas GP Delongchamps NB Jones RF 2007J Nation Cancer Inst2007,99,19:1
6The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS) 显示文摘Haas PS Roy NB Gibbons RJ 2009Br J Hematol2009,144,4:1
7A phase II trial of doxoru bicin and gemeitabine in renal cell carcinoma with sarcomatoid features: ECOG8802显示文摘Haas NB Lin X Manola J 2012Med 0ncol2012,29,2:1
8A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features:ECOG 8802显示文摘Haas NB Lin X Manola J 0,,02:1
9Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence 显示文摘Haas GP Delongchamps NB Jones RF 2007Nat Cancer Inst2007,99,19:1
10Clinical pharmacokinetic and biological tudies of topotecan显示文摘O'Dwyer PJ Lacreta FP Haas NB 1994Cancer Chemother Pharmacol1994,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费